Skip to main content

ADVERTISEMENT

Ian M. Cawich, MD

Drs N'Dandu, Cawich, Nair
Video
08/14/2023
Dr. Pradeep Nair is joined by Dr. Zola N’Dandu and Dr. Ian Cawich to discuss complex cases and share how BD’s innovative suite of products help them treat patients with peripheral arterial disease.
Dr. Pradeep Nair is joined by Dr. Zola N’Dandu and Dr. Ian Cawich to discuss complex cases and share how BD’s innovative suite of products help them treat patients with peripheral arterial disease.
Dr. Pradeep Nair is joined by...
08/14/2023
Vascular Disease Management
Original Contribution
01/19/2022
In this study, we aimed to describe the immediate and long-term vascular effects of OAS in patients with peripheral arterial disease (PAD) and moderate to severely calcified lesions.
In this study, we aimed to describe the immediate and long-term vascular effects of OAS in patients with peripheral arterial disease (PAD) and moderate to severely calcified lesions.
In this study, we aimed to...
01/19/2022
Journal of Invasive Cardiology
11/27/2018
The newest device that we have been able to use has been the 220 mm length version of the Lutonix 035 drug-coated balloon (BD/Bard). We have used this product since it launched in August and have done six cases thus far, all with great...
The newest device that we have been able to use has been the 220 mm length version of the Lutonix 035 drug-coated balloon (BD/Bard). We have used this product since it launched in August and have done six cases thus far, all with great...
The newest device that we have...
11/27/2018
Cath Lab Digest
Original Contribution
05/28/2021
The aim of this study was to determine whether there are racial differences in outcomes of patients with PAD undergoing endovascular treatment. 
The aim of this study was to determine whether there are racial differences in outcomes of patients with PAD undergoing endovascular treatment. 
The aim of this study was to...
05/28/2021